Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 37,855 $ 87,721
Marketable securities, current 45,720 10,234
Prepaid expenses 2,005 2,244
Accounts receivable from related party 295 240
Other current assets 5,085 4,424
Total current assets 90,960 104,863
Operating lease right-of-use assets, non-current 11,131 0
Property and equipment, net 7,108 6,851
In-process research and development 26,623 26,623
Other assets 4,783 1,821
Total assets 140,605 140,158
Current liabilities:    
Accounts payable 1,582 780
Accrued liabilities 5,979 5,357
Deferred revenue, current 19,307 26,231
Other current liabilities 1,232 141
Total current liabilities 28,100 32,509
Deferred revenue, non-current 2,065 2,670
Long-term debt, net 3,159 3,254
Operating lease liabilities, non-current 10,770 0
Other liabilities 374 819
Total liabilities 44,468 39,252
Commitments and contingencies (Note 9)
Stockholders’ equity    
Common stock $0.001 par value Authorized: 150,000,000 shares; issued and outstanding: 36,756,651 shares at March 31, 2019 and 36,736,012 shares at December 31, 2018 37 37
Additional paid-in capital 196,972 195,573
Accumulated other comprehensive loss 0 0
Accumulated deficit (100,872) (94,704)
Total stockholders’ equity 96,137 100,906
Total liabilities and stockholders’ equity $ 140,605 $ 140,158